Abstract:Hepatic encephalopathy (HE) is a major neuropsychiatric complication of cirrhosis. HE develops slowly in cirrhotic patients, starting with altered sleep patterns and eventually progressing through asterixis to stupor and coma. Precipitating factors are common and include an oral protein load, gastrointestinal bleeding and the use of sedatives. HE is common following transjugular intrahepatic portosystemic stent shunts (TIPS). Neuropathologically, HE in cirrhotic patients is characterized by astrocytic (rather than neuronal) changes known as Alzheimer type II astrocytosis and in altered expression of key astrocytic proteins. Magnetic resonance imaging in cirrhotic patients reveals bilateral signal hyperintensities particularly in globus pallidus on T1-weighted imaging, a phenomenon which may result from manganese deposition. Proton (1H) magnetic resonance spectroscopy shows increases in the glutamine resonance in brain, a finding which confirms previous biochemical studies and results no doubt from increased brain ammonia removal (glutamine synthesis). Additional evidence for increased brain ammonia uptake and removal in cirrhotic patients is provided by studies using positron emission tomography and 13NH3. Recent molecular biological studies demonstrate increased expression of genes coding for neurotransmitter-related proteins in chronic liver failure. Such genes include monoamine oxidase (MAO-A isoform), the peripheral-type benzodiazepine receptor and nitric oxide synthase (nNOS isoform). Activation of these systems has the potential to lead to alterations of monoamine and amino acid neurotransmitter function as well as modified cerebral perfusion in chronic liver failure. Prevention and treatment of HE in cirrhotic patients continues to rely on ammonia-lowering strategies which include assessment of dietary protein intake and the use of lactulose, neomycin, sodium benzoate and L-ornithine-aspartate. The benzodiazepine receptor antagonist flumazenil may be effective in certain cases. A more widespread use of central nervous system-acting drugs awaits a more complete understanding of the precise neurotransmitter systems involved in the pathogenesis of HE in chronic liver failure.

Abstract No. 591 Splenic Artery Embolization for the Treatment of Hepatic Encephalopathy: A Literature Review

Advancements in Interventional Radiology for Managing Hepatic Encephalopathy: A Comprehensive Review

Safety and efficacy of interventional embolization in cirrhotic patients with refractory hepatic encephalopathy associated with spontaneous portosystemic shunts

Splenic Vein Embolization As a Feasible Treatment for Patients with Hepatic Encephalopathy Related to Large Spontaneous Splenorenal Shunts.

Embolotherapy in the Management of Hepatocellular Carcinoma.

The assessment and management of cirrhotic patients with encephalopathy

Combined Spontaneous Portosystemic Shunt Embolization and Transjugular Intrahepatic Portosystemic Shunt Creation for Treatment of Hepatic Encephalopathy

Hepatic Encephalopathy following Transjugular Intrahepatic Portosystemic Shunt Placement

Interventional embolisation for patients with cirrhosis and recurrent or persistent hepatic encephalopathy related to spontaneous portosystemic shunts: protocol for a prospective, non-randomised controlled study

Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation

Hepatic encephalopathy – recent advances in treatment and diagnosis

Hepatic encephalopathy: current challenges and future prospects

Rmhp_a_234628 135..140

The neurogliovascular unit in hepatic encephalopathy

Complications of cirrhosis III. Hepatic encephalopathy

Advances in the diagnosis and treatment of hepatic encephalopathy

80 SAFETY AND TOLERABILITY OF HUMAN MESENCHYMAL STEM CELLS FOR PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A PRELIMINARY STUDY

Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis.

Arterioportal Shunts in Patients with Hepatocellular Carcinoma Treated Using Ethanol-Soaked Gelatin Sponge: Therapeutic Effects and Prognostic Factors

Acute Pancreatitis Associated Left-Sided Portal Hypertension with Severe Gastrointestinal Bleeding Treated by Transcatheter Splenic Artery Embolization: a Case Report and Literature Review

Splenic Artery Embolization as an Adjunctive Procedure for Portal Hypertension